Bertelsmann Stiftung: Where leading countries stand in the transition to renewable heating, road transport and electricity
The sluggish rate of progress made in the energy transition is putting the goal of reducing greenhouse gas emissions to zero by the middle of the century at risk. A comparison of four European countries shows that Denmark and Norway are making significant strides in transitioning to renewable heating and electricity. Norway is also advancing quickly in the road transport sector. The UK and Germany continue to face several challenges.
Gütersloh, 01.10.2024. To achieve climate neutrality, interim targets are crucial. In the electricity supply sector, for example, the energy transition must be completed by 2035. “Beyond emissions data, we need early warning indicators track infrastructure development and ensure political measures supporting acceleration,” says Christof Schiller, governance expert at the Bertelsmann Stiftung and head of the Sustainable Governance Indicators (SGI).
A study by the Research Institute for Sustainability – Helmholtz Centre Potsdam (RIFS) and the Bertelsmann Stiftung applies this approach to the electricity, road transport, and heating sectors. It shows how close countries are to climate neutrality, where they face challenges, and how progress can be accelerated. Each sector sees at least one country making significant headway: Denmark and Norway lead in green electricity and heating, with Norway nearly completing its e-mobility shift. Germany and the UK, however, still lag behind. Decarbonization by mid-century is achievable, but only if policy targets, regulations, and infrastructure are better aligned.
Accelerating Germany’s renewable electricity transition demands clear targets for expanding grids, boosting storage, and better aligning transmission goals. The UK requires similar targets, plus a plan to phase out gas production. Denmark, with its clear targets, could fully transition to green electricity by 2029. Norway has already decarbonized its electricity supply.
Germany’s high electric vehicle costs and lack of charging stations hinder short-term e-mobility growth. The decline in combustion engine vehicles is currently not enough to ensure zero emissions by 2045. Denmark and the UK also need more consistent strategies, while Norway is set to reach 100% electric vehicle sales next year, thanks to early financial incentives. “Norway's progress in e-mobility is based on the early actions taken to provide financial incentives for emission-free vehicles,” says Thorsten Hellmann, an economics expert at the Bertelsmann Stiftung.
In the heating sector, Germany must double heat pump installations to meet 2030 goals, while the UK lags further behind. Denmark excels in emission-free heating, having banned oil and gas boilers in 2013, and Norway expects full heat pump coverage by 2030.
Dr. Christof Schiller, phone: +49 030 275788-138
E-Mail: christof.schiller@bertelsmann-stiftung.de
Thorsten Hellmann, phone +49 5241 8181-236
E-Mail: thorsten.hellmann@bertelsmann-stiftung.de
About the Bertelsmann Stiftung: Inspiring people. Shaping the future.
The Bertelsmann Stiftung is committed to ensuring that everyone in society can participate in political, economic and cultural life. Our programs: Education and Next Generation, Democracy and Social Cohesion, Digitalization and the Common Good, Europe’s Future, Health, and Sustainable Social Market Economies. A nonprofit foundation, the Bertelsmann Stiftung was established in 1977 by Reinhard Mohn.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom